Cite
APA Citation
Young-Xu, Y., Melsheimer, R., Emond, B., Lefebvre, P., DerSarkissian, M., Lax, A., Nguyen, C., Bhak, R. H., Wu, M., & Lin, I. (2022). author's Response to Letter to the Editor - Re: Lin I, Melsheimer R, Bhak RH, et al. Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab. Curr Med Res Opin. 2022;38(4):613–627. Current medical research and opinion, 38, 2237–2240. http://access.bl.uk/ark:/81055/vdc_100171889643.0x000048